CVS Health Corporation $CVS Stock Holdings Lessened by State Street Corp

CVS Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • State Street cut its CVS stake by 19.8% in the third quarter, selling about 14.84 million shares; it still held 60.09 million shares, or roughly 4.7% of the company.
  • CVS reported quarterly adjusted earnings of $2.09 per share, beating the $1.65 consensus, while revenue rose 5.4% year over year to $108.4 billion.
  • Analysts maintained a broadly positive view: CVS had a “Moderate Buy” consensus rating and an average price target of $107.33; an executive also bought 23,855 shares.
  • Five stocks we like better than CVS Health.

State Street Corp lessened its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 19.8% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 60,087,270 shares of the pharmacy operator's stock after selling 14,839,794 shares during the quarter. State Street Corp owned about 4.70% of CVS Health worth $5,148,878,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of CVS. Elevation Wealth Partners LLC raised its holdings in CVS Health by 41.8% in the 2nd quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator's stock valued at $37,000 after acquiring an additional 105 shares during the period. HBW Advisory Services LLC lifted its position in CVS Health by 3.5% during the third quarter. HBW Advisory Services LLC now owns 3,408 shares of the pharmacy operator's stock worth $292,000 after acquiring an additional 115 shares during the last quarter. Apella Capital LLC boosted its holdings in shares of CVS Health by 1.7% during the second quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator's stock worth $724,000 after acquiring an additional 117 shares during the period. Wellington Altus USA Inc. boosted its holdings in shares of CVS Health by 13.3% during the second quarter. Wellington Altus USA Inc. now owns 1,025 shares of the pharmacy operator's stock worth $106,000 after acquiring an additional 120 shares during the period. Finally, Childress Capital Advisors LLC grew its position in shares of CVS Health by 3.9% in the third quarter. Childress Capital Advisors LLC now owns 3,497 shares of the pharmacy operator's stock valued at $300,000 after purchasing an additional 131 shares during the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Performance

NYSE CVS opened at $80.83 on Friday. The firm has a 50-day moving average price of $88.42 and a two-hundred day moving average price of $89.29. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68. The company has a market capitalization of $103.42 billion, a P/E ratio of 9.41, a P/E/G ratio of 0.77 and a beta of 0.58. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, beating analysts' consensus estimates of $1.65 by $0.44. The company had revenue of $108.40 billion during the quarter, compared to the consensus estimate of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The firm's quarterly revenue was up 5.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.60 earnings per share. Analysts anticipate that CVS Health Corporation will post 8.26 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were given a dividend of $0.6650 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date was Thursday, October 22nd. CVS Health's dividend payout ratio is presently 30.97%.

Insider Activity

In related news, EVP Prem Shah purchased 23,855 shares of the firm's stock in a transaction that occurred on Friday, November 6th. The shares were bought at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the transaction, the executive vice president owned 88,516 shares of the company's stock, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.85% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. BMO Capital Markets set a $112.00 target price on CVS Health in a research note on Wednesday, September 9th. Royal Bank Of Canada reduced their price target on CVS Health from $113.00 to $108.00 and set an "outperform" rating for the company in a research note on Monday, November 16th. Weiss Ratings upgraded CVS Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Monday, November 9th. Robert W. Baird set a $107.00 price objective on CVS Health in a report on Thursday, August 6th. Finally, Piper Sandler set a $106.00 price objective on CVS Health in a research report on Friday, November 13th. Twenty-three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and an average target price of $107.33.

Read Our Latest Stock Report on CVS Health

CVS Health News Roundup

Here's some of the latest news about CVS:

CVS Health Company Profile

(Free Report)

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Further Reading

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CVS Health Right Now?

Before you consider CVS Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.

While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, NVIDIA, and Google Cover

Could the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines